<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T19:54:28Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:4180014" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:4180014</identifier><datestamp>2014-10-02</datestamp><setSpec>elsevierwt</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Metabolism</journal-id>
      <journal-id journal-id-type="iso-abbrev">Metab. Clin. Exp</journal-id>
      <journal-title-group>
        <journal-title>Metabolism</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0026-0495</issn>
      <issn pub-type="epub">1532-8600</issn>
      <publisher>
        <publisher-name>W.B. Saunders</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC4180014</article-id>
      <article-id pub-id-type="pmcid">PMC4180014</article-id>
      <article-id pub-id-type="pmc-uid">4180014</article-id>
      <article-id pub-id-type="pmid">25060689</article-id>
      <article-id pub-id-type="publisher-id">S0026-0495(14)00177-2</article-id>
      <article-id pub-id-type="doi">10.1016/j.metabol.2014.06.010</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Clinical Science</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Leptin modulates autophagy in human CD4<sup>+</sup>CD25<sup>â</sup> conventional T cells</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Cassano</surname>
            <given-names>Silvana</given-names>
          </name>
          <xref rid="af0005" ref-type="aff">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pucino</surname>
            <given-names>Valentina</given-names>
          </name>
          <xref rid="af0010" ref-type="aff">b</xref>
          <xref rid="fn0005" ref-type="fn">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>La Rocca</surname>
            <given-names>Claudia</given-names>
          </name>
          <xref rid="af0005" ref-type="aff">a</xref>
          <xref rid="af0015" ref-type="aff">c</xref>
          <xref rid="fn0005" ref-type="fn">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Procaccini</surname>
            <given-names>Claudio</given-names>
          </name>
          <xref rid="af0005" ref-type="aff">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>De Rosa</surname>
            <given-names>Veronica</given-names>
          </name>
          <xref rid="af0005" ref-type="aff">a</xref>
          <xref rid="af0025" ref-type="aff">e</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Marone</surname>
            <given-names>Gianni</given-names>
          </name>
          <xref rid="af0010" ref-type="aff">b</xref>
          <xref rid="af0020" ref-type="aff">d</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Matarese</surname>
            <given-names>Giuseppe</given-names>
          </name>
          <email>gmatarese@unisa.it</email>
          <xref rid="af0030" ref-type="aff">f</xref>
          <xref rid="af0035" ref-type="aff">g</xref>
          <xref rid="cr0005" ref-type="corresp">â</xref>
        </contrib>
      </contrib-group>
      <aff id="af0005"><label>a</label>Laboratorio di Immunologia, Istituto di Endocrinologia e Oncologia Sperimentale, Consiglio Nazionale delle Ricerche (IEOS-CNR), 80131 Napoli, Italy</aff>
      <aff id="af0010"><label>b</label>Dipartimento di Scienze Mediche Traslazionali, UniversitÃ  di Napoli âFederico IIâ, 80131 Napoli, Italy</aff>
      <aff id="af0015"><label>c</label>Dipartimento di Medicina Molecolare e Biotecnologie Mediche, UniversitÃ  di Napoli âFederico IIâ, 80131 Napoli, Italy</aff>
      <aff id="af0020"><label>d</label>Centro Interdipartimentale di Ricerca in Scienze Immunologiche di Base e Cliniche (CISI), UniversitÃ  di Napoli âFederico IIâ, 80131 Napoli, Italy</aff>
      <aff id="af0025"><label>e</label>UnitÃ  di NeuroImmunologia, IRCCS-Fondazione Santa Lucia, 00143 Roma, Italy</aff>
      <aff id="af0030"><label>f</label>Dipartimento di Medicina e Chirurgia, FacoltÃ  di Medicina e Chirurgia, UniversitÃ  di Salerno, Baronissi Campus, 84081 Baronissi, Salerno, Italy</aff>
      <aff id="af0035"><label>g</label>IRCCS-MultiMedica, 20138 Milano, Italy</aff>
      <author-notes>
        <corresp id="cr0005"><label>â</label>Corresponding author at: Dipartimento di Medicina e Chirurgia, UniversitÃ  di Salerno, Baronissi Campus, 84081 Baronissi, Salerno, Italy. <email>gmatarese@unisa.it</email></corresp>
        <fn id="fn0005">
          <label>1</label>
          <p>These authors contributed equally to this work.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="pmc-release">
        <day>1</day>
        <month>10</month>
        <year>2014</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="ppub">.-->
      <pub-date pub-type="ppub">
        <month>10</month>
        <year>2014</year>
      </pub-date>
      <volume>63</volume>
      <issue>10</issue>
      <fpage>1272</fpage>
      <lpage>1279</lpage>
      <history>
        <date date-type="received">
          <day>16</day>
          <month>5</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>14</day>
          <month>6</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Â© 2014 The Authors</copyright-statement>
        <copyright-year>2014</copyright-year>
        <license license-type="CC BY-NC-ND" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/">
          <license-p> This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).</license-p>
        </license>
      </permissions>
      <abstract>
        <sec>
          <title>Objective</title>
          <p>In this report we show that the adipocytokine leptin directly modulates autophagy in human CD4<sup>+</sup>CD25<sup>â</sup> conventional (Tconv) T cells.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p><italic>In vitro</italic> treatment with recombinant human leptin determined an inhibition of autophagy during T cell receptor (TCR) stimulation, and this phenomenon was dose- and time-dependent. The events were secondary to the activation of the mammalian-target of rapamycin (mTOR)-pathway induced by leptin, as testified by its reversion induced by mTOR inhibition with rapamycin. At molecular level these phenomena associated with Bcl-2 up-regulation and its interaction with Beclin-1, whose complex exerts a negative effect on autophagy.</p>
        </sec>
        <sec>
          <title>Materials/methods</title>
          <p>The impact of leptin on autophagy of Tconv cells was determined at biochemical level by western blotting and by flow cytometry; the interaction between BCL-2 and Beclin-1 by co-immunoprecipitation assays.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>Our results, suggest that in unconditioned, freshly-isolated human Tconv cells, autophagy and proliferation are controlled by leptin during TCR-engagement, and that both phenomena occur alternatively indicating a balance between these processes during immune activation.</p>
        </sec>
      </abstract>
      <kwd-group>
        <title>Abbreviations</title>
        <kwd>mTOR, mammalian-target of rapamycin</kwd>
        <kwd>TCR, T cell receptor</kwd>
        <kwd>hLepRb, human leptin receptor-b</kwd>
        <kwd>LC3-II, microtubule associated protein light chain 3-II</kwd>
        <kwd>Tconv, T conventional</kwd>
      </kwd-group>
      <kwd-group>
        <title>Keywords</title>
        <kwd>Leptin</kwd>
        <kwd>Autophagy</kwd>
        <kwd>T cells</kwd>
        <kwd>Metabolism</kwd>
        <kwd>mTOR</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="s0005">
      <label>1</label>
      <title>Introduction</title>
      <p>Leptin is a 16Â kD adipocyte-derived cytokine that regulates neuroendocrine functions and controls food intake, energy expenditure, glucose and fat metabolisms <xref rid="bb0005" ref-type="bibr">[1]</xref>. It mediates its functions through the long form of the leptin receptor (LepRb) which is part of the class I cytokine receptors, expressed at different levels also on innate and adaptive immune cells including monocytes, dendritic cells (DCs), B and T cells, respectively <xref rid="bb0010" ref-type="bibr">[2]</xref>. In this context, it has been previously suggested that leptin represents an important link among nutritional status, metabolism, and immune responses <xref rid="bb0015 bb0020" ref-type="bibr">[3,4]</xref>, indeed it signals to CD4<sup>+</sup> T cells that sufficient amount of energy is stored as fat to support the increased energy demand during immune responses against pathogens <xref rid="bb0025" ref-type="bibr">[5]</xref>. Also, leptin shows differential effects on several T cell subpopulations <xref rid="bb0030 bb0035" ref-type="bibr">[6,7]</xref> through the activation of the mammalian target of rapamycin (mTOR) pathway <xref rid="bb0035 bb0040 bb0045" ref-type="bibr">[7â9]</xref>. mTOR is a molecular sensor of cellular nutritional status and integrates signals from the environment to the nucleus for the regulation of cell metabolism, proliferation, survival and autophagy <xref rid="bb0050" ref-type="bibr">[10]</xref>. mTOR plays a negative role on cellular autophagy <xref rid="bb0055 bb0060 bb0065 bb0070" ref-type="bibr">[11â14]</xref>: autophagy, from the Greek words, <italic>auto</italic> âselfâ and <italic>phagein</italic> âto eatâ, is the basic catabolic mechanism that involves cell degradation of unnecessary or dysfunctional cellular components through the actions of lysosomes. The breakdown of cellular components can ensure cell survival during reduced energy availability (ie. starvation) by maintaining cellular energy levels <xref rid="bb0075" ref-type="bibr">[15]</xref>. During this process, targeted cytoplasmic constituents are isolated from the rest of the cell within the autophagosomes, which are then fused with lysosomes and degraded or recycled. The molecular mechanism by which mTOR inhibits autophagy is not completely understood. Over the past few years, autophagy has been considered as a process that provides a survival advantage to cells undergoing nutrient deprivation or other stresses <xref rid="bb0065 bb0070 bb0075" ref-type="bibr">[13â15]</xref>. Indeed genetic or pharmacological alterations in autophagy impair cell survival rate or cell metabolism, thereby affecting tissue homeostasis. In the context of the immune system, recent papers have shown that autophagy may be also linked to apoptosis <xref rid="bb0080 bb0085 bb0090" ref-type="bibr">[16â18]</xref> and might play different roles in lymphocyte development <xref rid="bb0095 bb0100 bb0105" ref-type="bibr">[19â21]</xref> and function, by maintaining the normal number of B, CD4<sup>+</sup>, CD8<sup>+</sup> T cells <xref rid="bb0110 bb0115" ref-type="bibr">[22,23]</xref> and controlling T cells activation <xref rid="bb0090" ref-type="bibr">[18]</xref>, thymic selection <xref rid="bb0120" ref-type="bibr">[24]</xref> and antigen presentation <xref rid="bb0125" ref-type="bibr">[25]</xref>. These data indicate that autophagy plays a role in switching the cell fate toward differentiation or specific functional commitments, such as T cell polarization, suggesting that metabolic state (through leptin) might influence this process. Moreover, leptin has been demonstrated to exert opposite effects on human regulatory CD4<sup>+</sup>CD25<sup>+</sup> (Treg) and conventional CD4<sup>+</sup>CD25<sup>â</sup> (Tconv) T cells: indeed it inhibits Treg cell proliferation <xref rid="bb0030" ref-type="bibr">[6]</xref>, on the one side, whereas it enhances Tconv proliferation, on the other <xref rid="bb0035" ref-type="bibr">[7]</xref>. These effects on both cellular subsets were induced by mTOR activation <xref rid="bb0035 bb0040" ref-type="bibr">[7,8]</xref>. Particularly, on Tconv cells the enhancement in their proliferation associated with inflammatory cytokine secretion, whereas leptin neutralization determined the inhibition of their responses, thus suggesting a key role of this adipocytokine in Tconv cells homeostasis and function and in pathogenesis of several inflammatory and autoimmune disease <xref rid="bb0130" ref-type="bibr">[26]</xref>. Levels of leptin are, in fact, typically low during infection and high in autoimmune disorders, both systemically and at the site of inflammation (ie. multiple sclerosis (MS), systemic lupus erythematosus (SLE), rheumatoid arthritis (RA)) <xref rid="bb0130 bb0135" ref-type="bibr">[26,27]</xref>. In this context, this report investigates the role of leptin, considered as a âdominantâ peripheral signal of fuel availability, on the modulation of the autophagic process in the context of human Tconv cells biology.</p>
    </sec>
    <sec sec-type="materials|methods" id="s0010">
      <label>2</label>
      <title>Materials and methods</title>
      <sec id="s0015">
        <label>2.1</label>
        <title>Cell cultures, purification and proliferation assays</title>
        <p>The leptin-dependent BAF/3-LepRb<sup>+</sup> cell line, stably transfected with the long form of human leptin receptor was kindly provided by Prof. Arieh Gertler from the Hebrew University, Rehovot, Israel. In brief, BAF/3-hLepRb<sup>+</sup> cells were cultured in RPMI-1640 medium in the presence of human leptin (10Â ng/mL), supplemented with 10% FCS, 2Â mmol/L L-glutamine, 100 units/mL penicillin, and 100Â Î¼g/mL streptomycin (Life Technologies, Carlsbad, CA). Cells were cultured at 37Â Â°C in 100% humidity and 5% CO<sub>2</sub>. To evaluate the leptin effects on autophagy, in all experiments, BAF/3-hLepRb<sup>+</sup> cells (1â2Â ÃÂ 10<sup>6</sup> cells/well) were leptin deprived for 12Â h and left in low serum (2% FCS). The day after they were acutely stimulated with recombinant human leptin (100Â ng/mL) (R&amp;D Systems, Minneapolis, MN) at times shown in figures.</p>
        <p>Human CD4<sup>+</sup>CD25<sup>â</sup> Tconv cells were purified from PBMCs from buffy coats of human healthy donors by either magnetic cell separation with the Dynabeads Treg Cell Kit (Invitrogen) or by FACS sorting (MoFlo, Dako-Beckman-Coulter), and Tconv cells purity was always between 95 and 98%. The study was approved by the Federico II Ethics Review Board and donors gave informed written consent for the blood donation. Cells (1â2Â ÃÂ 10<sup>6</sup> cells/well) were washed extensively with serum free culture medium, left in low serum [2% AB human serum (Invitrogen)] for 2Â h at 37Â Â°C in presence of lysosomal protease inhibitor [NH<sub>4</sub>Cl (20Â mmol/L) and leupeptin (100Â Î¼mol/L) (Sigma)], and after were washed and stimulated or not with recombinant human leptin (100â200Â ng/mL) (R&amp;D Systems, Minneapolis, MN) plus anti-CD3/CD28 mAbs coated beads (0.2 beads/cell, Invitrogen) for 2Â h at 37Â Â°C. For proliferation assays, Tconv cells were stimulated or not with human leptin (200Â ng/mL) and human leptin-neutralizing mAb (R&amp;D Systems, Minneapolis, MN), used at a final concentration of 0.25 to 25Â mg/mL. For transient mTOR inhibition, either BAF/3-hLepRb<sup>+</sup> or Tconv cells were pre-treated for 1Â h with rapamycin (Sigma-Aldrich) at final concentration of 100Â nmol/L. Cells were stimulated for 3Â days, labeled with [3H]thymidine (0.5Â mCi/well) (Amersham-Pharmacia Biotech, Cologno Monzese, Italy) for the last 16Â h of culture, and harvested after 12Â h (Tomtec). Radioactivity was measured with a Î²-cell-plate scintillation counter (Wallac, Gaithersburg, MD). For mouse studies, 8â10-wk-old C57BL/6J (B6) wild-type (WT), and leptinâdeficient mice (C57BL/6J-<italic>ob/ob</italic>) were purchased from Charles River Laboratories (Calco, Italy). The study was approved by the Ethical Veterinary Board of the Federico II University.</p>
        <p>For biochemical analyses on mouse cells, 1â2Â ÃÂ 10<sup>6</sup> Tconv cells (isolated by negative selection using the Miltenyi Biotec Treg Cell Isolation kit and an AutoMACS cell separator, cell purity &gt;Â 95%), were obtained from the splenocytes of each group of WT or C57BL/6J-<italic>ob/ob</italic> mice and left for 12Â h in 2% FCS, 2Â mmol/L L-glutamine, 100 units/mL penicillin, and 100Â Î¼g/mL streptomycin (Life Technologies, Carlsbad, CA). The day after, cells were stimulated for 2Â h with mouse recombinant leptin (200Â ng/mL) (R&amp;D Systems, Minneapolis, MN).</p>
      </sec>
      <sec id="s0020">
        <label>2.2</label>
        <title>MDC assay</title>
        <p>BAF/3-hLepRb<sup>+</sup> cells, starved as previously described, were incubated with 0.05Â mmol/L monodansyl-cadaverine (MDC) (Sigma Aldrich) at 37Â Â°C for 10Â min in presence or absence of leptin and analyzed by FACS (FACS-Canto Becton-Dickinson, San Diego, CA) and analyses were performed by Flow-Jo software (Tree Star, Ashland, OR).</p>
      </sec>
      <sec id="s0025">
        <label>2.3</label>
        <title>Immunoblotting analyses</title>
        <p>Total cell lysates were prepared by dissolving the cell pellet in cold radioimmune precipitation assay buffer RIPA (50Â mmol/L TrisâHCl, pHÂ 7.5, 150Â mmol/L NaCl, 1% Nonidet P-40, 0.5% deoxycholate, 0.1% SDS and a mixture of protease and phosphatase inhibitors) for 15Â min at 4Â Â°C. The lysate was centrifuged (10,000Â ÃÂ <italic>g</italic> for 10Â min); the supernatant was collected, quantized and resuspended in electrophoresis sample buffer, heated to 95Â Â°C for 5Â min and resolved on a SDS 15% polyacrylamide gel. Western blot with specific antibodies were used according to the protocol provided by the supplier. For all western blot shown 20Â Î¼g of total protein extracts was loaded; antibodies used were: anti-LC3 A/B, anti-phospho-STAT3 and anti-STAT3, anti-phospho-S6, anti-S6, (Cell Signaling Technology, Beverly, MA); anti-ERK1/2, anti-phospho-ERK1/2, anti-Bcl-2 and anti-actin (all from Santa Cruz Biotechnology, Santa Cruz, CA). Lysosomal protease inhibitors NH<sub>4</sub>Cl plus leupeptin (Sigma) were used, at final concentration of 20Â mmol/L and 100Â Î¼mol/L respectively, to better preserve the amount of LC3-II.</p>
      </sec>
      <sec id="s0030">
        <label>2.4</label>
        <title>Co-immunoprecipitation</title>
        <p>BAF/3-hLepRb<sup>+</sup> cells (14Â ÃÂ 10<sup>7</sup>) were lysed in HEMG buffer (25Â mmol/L HEPES (pHÂ 8.0), 100Â mmol/L NaCl, 0.5% Nonidet P-40, 0.1Â mmol/L EDTA, 10% glycerol) plus protease and phosphatase inhibitors to detect endogenous BeclinâBcl-2 complex. Equal amounts of protein (400Â Î¼g per experimental point) were incubated with a mouse monoclonal anti-Bcl-2 Ab (Santa Cruz Biotechnology) and a mouse pre-immune IgG at the same concentration overnight at 4Â Â°C. The conditions used were in according to the protocol provided by the supplier. Eluates were resolved on a SDS 12% polyacrylamide gel and detected by WB with a rabbit anti-Beclin-1 Ab (Cell Signaling) and a rabbit anti-Bcl-2 Ab (Santa Cruz Biotechnology).</p>
      </sec>
      <sec id="s0035">
        <label>2.5</label>
        <title>Statistical analysis</title>
        <p>We used non-parametric MannâWhitney <italic>U</italic> tests. The statistical software used was GraphPad InStat3 version 4.0. Results are expressed as meanÂ Â±Â S.E.M. <italic>P</italic> values &lt;Â 0.05 were considered statistically significant.</p>
      </sec>
    </sec>
    <sec sec-type="results" id="s0040">
      <label>3</label>
      <title>Results</title>
      <sec id="s0045">
        <label>3.1</label>
        <title>Human leptin modulates proliferation and autophagy of BAF/3-hLepRb<sup>+</sup> cells</title>
        <p>To assess the role of leptin in the modulation of the autophagic process we firstly utilized an immortalized cell line, BAF3, stably transfected with the full-length human leptin receptor (hLepRb) (see Methods for details) whose proliferation <italic>in vitro</italic> has been previously shown to be totally dependent on presence of leptin in culture medium. Firstly, we performed human recombinant leptin dose responses <italic>in vitro</italic> by measuring proliferation of the BAF/3-hLepRb<sup>+</sup> cell line (<xref rid="f0005" ref-type="fig">Fig.Â 1</xref>A). Human leptin induced a dose-dependent proliferation of BAF/3-hLepRb<sup>+</sup> cells through the engagement of LepRb since the phenomenon was completely abrogated by leptin neutralization with an anti-leptin mAb (<xref rid="f0005" ref-type="fig">Fig.Â 1</xref>A). These events were secondary to leptin-LepRb-STAT3 activation as suggested by increase in the P-STAT3 levels (<xref rid="f0005" ref-type="fig">Fig.Â 1</xref>B left). Indeed, in time course experiments, P-STAT3 revealed an oscillatory trend reaching a maximal activation at 30â² rapidly subsiding after 60â²â120â². To evaluate whether leptin plays also a role on mTOR regulation, we analyzed P-STAT3 levels in presence of rapamycin, a potent mTOR inhibitor. Transient inhibition of mTOR (1Â h of rapamycin pre-treatment) significantly reduced the amount of P-STAT3 (<xref rid="f0005" ref-type="fig">Fig.Â 1</xref>B right); also, leptin treatment after rapamycin pretreatment, was able to restore P-STAT3 levels albeit to a lower extent at 30â² (<xref rid="f0005" ref-type="fig">Fig.Â 1</xref>B right). To get further insights into mTOR pathways activity, we analyzed S6 phosphorylation, a downstream target of mTOR activity. Phospho-S6 was rapidly induced by leptin treatment and significantly inhibited by rapamycin pre-treatment. These phenomena were partly reversed by leptin (<xref rid="f0005" ref-type="fig">Fig.Â 1</xref>C right).</p>
        <p>To evaluate the effect of leptin on the autophagic machinery, we used two different approaches: 1) flow cytometry analysis of the autofluorescent drug monodansyl-cadaverine (MDC), which is a specific autophagolysosome marker; 2) western blotting analysis of the microtubule associated protein light chain 3-II (LC3-II) protein, a well known marker of autophagy, by analyzing the conversion of LC3-I in LC3-II (autophagic flux) as LC3-II/LC3-I ratio. Leptin treatment significantly reduced the amount of MDC (<xref rid="f0005" ref-type="fig">Fig.Â 1</xref>D) and of LC3-II/LC3-I ratio (<xref rid="f0005" ref-type="fig">Fig.Â 1</xref>E), this inhibitory effect on autophagy was maximal at 60â120Â min (<xref rid="f0005" ref-type="fig">Fig.Â 1</xref>E left). Finally, to evaluate whether leptin effects on autophagy could be mediated by mTOR pathway modulation, we studied this phenomenon in presence of rapamycin (<xref rid="f0005" ref-type="fig">Fig.Â 1</xref>E right). As expected, rapamycin alone increased autophagy and the phenomenon was reversed by leptin (<xref rid="f0005" ref-type="fig">Fig.Â 1</xref>E right). To rule out that LC3-II/LC3-I reduction was induced by leptin and not due to lysosomal proteases degradation, we tested the autophagic flux in presence or absence of lysosomal protease inhibitors (NH<sub>4</sub>Cl/leupeptin) (<xref rid="ec0005" ref-type="supplementary-material">Supplemental Fig.Â 1</xref>), confirming that the observed phenomenon was specifically reduced by leptin.</p>
        <p>To evaluate the effect of leptin on the autophagic machinery, we used two different approaches: 1) flow cytometry analysis of the autofluorescent drug monodansyl-cadaverine (MDC), which is a specific autophagolysosome marker; 2) western blotting analysis of the microtubule associated protein light chain 3-II (LC3-II) protein, a well known marker of autophagy, by analyzing the conversion of LC3-I in LC3-II (autophagic flux) as LC3-II/LC3-I ratio. Leptin treatment significantly reduced the amount of MDC (<xref rid="f0005" ref-type="fig">Fig.Â 1</xref>D) and of LC3-II/LC3-I ratio (<xref rid="f0005" ref-type="fig">Fig.Â 1</xref>E), this inhibitory effect on autophagy was maximal at 60â120Â min (<xref rid="f0005" ref-type="fig">Fig.Â 1</xref>E left). Finally, to evaluate whether leptin effects on autophagy could be mediated by mTOR pathway modulation, we studied this phenomenon in presence of rapamycin (<xref rid="f0005" ref-type="fig">Fig.Â 1</xref>E right). As expected, rapamycin alone increased autophagy and the phenomenon was reversed by leptin (<xref rid="f0005" ref-type="fig">Fig.Â 1</xref>E right). To rule out that LC3-II/LC3-I reduction was induced by leptin and not due to lysosomal proteases degradation, we tested the autophagic flux in presence or absence of lysosomal protease inhibitors (NH<sub>4</sub>Cl/leupeptin) (Supplemental Fig. 1), confirming that the observed phenomenon was specifically reduced by leptin.</p>
      </sec>
      <sec id="s0050">
        <label>3.2</label>
        <title>TCR and hLepRb modulate autophagy in human Tconv cells</title>
        <p>To study the possible link between proliferation and autophagy in normal human T cells, we studied the autophagic flux also in highly purified, leptin-stimulated CD4<sup>+</sup>CD25<sup>â</sup> Tconv cells. We firstly, tested the capacity of leptin to affect Tconv cell proliferation in the presence or absence of mTOR inhibition (<xref rid="f0010" ref-type="fig">Fig.Â 2</xref>A). Indeed, we confirmed that leptin neutralization in the culture medium was able to inhibit Tconv proliferation (<xref rid="f0010" ref-type="fig">Fig.Â 2</xref>A): the phenomenon was specific since it was reversible upon readdition of leptin in cultures in the presence of anti-leptin neutralizing mAb. Rapamycin behaved similarly to the anti-leptin neutralizing mAb, since it inhibited Tconv cells proliferation and this inhibition was partly reversed by leptin. These experiments suggest that leptin supports T cell proliferation upon TCR-stimulation, and that these phenomena occurred <italic>via</italic> mTOR activation, since rapamycin was able to reduce T cell proliferation, phenomenon which was reversible <italic>in vitro</italic> by leptin treatment. Parallel biochemical analyses revealed that Tconv lymphocytes, in the presence of increasing leptin concentrations, reduced autophagy (<xref rid="f0010" ref-type="fig">Fig.Â 2</xref>B). Leptin alone on purified, not-stimulated Tconv cells was not able to reduce autophagy in a dose dependent manner; this phenomenon was strongly induced by CD3/CD28 stimulation alone, and addition of leptin during TCR stimulation enhanced this phenomenon in a dose dependent manner (<xref rid="f0010" ref-type="fig">Fig.Â 2</xref>B). In these experimental conditions, leptin induced S6-phosphorylation, and this increase was maintained also during CD3/CD28 stimulation (<xref rid="f0010" ref-type="fig">Fig.Â 2</xref>C), suggesting an additive effect on the mTOR pathway induced by parallel LepRb and TCR stimulation (<xref rid="f0010" ref-type="fig">Fig.Â 2</xref>C). Parallel, P-ERK1/2 analyses revealed little but significant effect of leptin on ERK1/2 phosphorylation which was not further potentiated after CD3/CD28 engagement (<xref rid="ec0010" ref-type="supplementary-material">Supplemental Fig.Â 2A</xref>). In this context we also repeated these experiments before and after rapamycin treatment, and again we confirmed a reduction in autophagy induced by leptin during CD3/CD28 stimulation, and the capacity of leptin to reverse autophagy induced by mTOR inhibition (<xref rid="f0010" ref-type="fig">Fig.Â 2</xref>D). These phenomena were accompanied by leptin induction of mTOR pathway activation as testified by increased S6-phosphorylation (<xref rid="f0010" ref-type="fig">Fig.Â 2</xref>E) while ERK1/2 phosphorylation was not potentiated by leptin during CD3/CD28 engagement (<xref rid="ec0010" ref-type="supplementary-material">Supplemental Fig.Â 2B</xref>) thus suggesting a direct and specific effect of leptin on the autophagic machinery during TCR engagement in Tconv cells through mTOR activation.</p>
        <p>To study the possible link between proliferation and autophagy in normal human T cells, we studied the autophagic flux also in highly purified, leptin-stimulated CD4<sup>+</sup>CD25<sup>â</sup> Tconv cells. We firstly, tested the capacity of leptin to affect Tconv cell proliferation in the presence or absence of mTOR inhibition (<xref rid="f0010" ref-type="fig">Fig.Â 2</xref>A). Indeed, we confirmed that leptin neutralization in the culture medium was able to inhibit Tconv proliferation (<xref rid="f0010" ref-type="fig">Fig.Â 2</xref>A): the phenomenon was specific since it was reversible upon readdition of leptin in cultures in the presence of anti-leptin neutralizing mAb. Rapamycin behaved similarly to the anti-leptin neutralizing mAb, since it inhibited Tconv cells proliferation and this inhibition was partly reversed by leptin. These experiments suggest that leptin supports T cell proliferation upon TCR-stimulation, and that these phenomena occurred <italic>via</italic> mTOR activation, since rapamycin was able to reduce T cell proliferation, phenomenon which was reversible <italic>in vitro</italic> by leptin treatment. Parallel biochemical analyses revealed that Tconv lymphocytes, in the presence of increasing leptin concentrations, reduced autophagy (<xref rid="f0010" ref-type="fig">Fig.Â 2</xref>B). Leptin alone on purified, not-stimulated Tconv cells was not able to reduce autophagy in a dose dependent manner; this phenomenon was strongly induced by CD3/CD28 stimulation alone, and addition of leptin during TCR stimulation enhanced this phenomenon in a dose dependent manner (<xref rid="f0010" ref-type="fig">Fig.Â 2</xref>B). In these experimental conditions, leptin induced S6-phosphorylation, and this increase was maintained also during CD3/CD28 stimulation (<xref rid="f0010" ref-type="fig">Fig.Â 2</xref>C), suggesting an additive effect on the mTOR pathway induced by parallel LepRb and TCR stimulation (<xref rid="f0010" ref-type="fig">Fig.Â 2</xref>C). Parallel, P-ERK1/2 analyses revealed little but significant effect of leptin on ERK1/2 phosphorylation which was not further potentiated after CD3/CD28 engagement (Supplemental Fig. 2A). In this context we also repeated these experiments before and after rapamycin treatment, and again we confirmed a reduction in autophagy induced by leptin during CD3/CD28 stimulation, and the capacity of leptin to reverse autophagy induced by mTOR inhibition (<xref rid="f0010" ref-type="fig">Fig.Â 2</xref>D). These phenomena were accompanied by leptin induction of mTOR pathway activation as testified by increased S6-phosphorylation (<xref rid="f0010" ref-type="fig">Fig.Â 2</xref>E) while ERK1/2 phosphorylation was not potentiated by leptin during CD3/CD28 engagement (Supplemental Fig. 2B) thus suggesting a direct and specific effect of leptin on the autophagic machinery during TCR engagement in Tconv cells through mTOR activation.</p>
      </sec>
      <sec id="s0055">
        <label>3.3</label>
        <title>Leptin regulates autophagy in Tconv cells through Bcl-2/Beclin-1 interaction</title>
        <p>To better understand the link between leptin and autophagy at molecular level we analyzed also in chronic leptin deficient mouse models such as the <italic>ob/ob</italic> mice, the levels of autophagy in isolated Tconv cells before and after leptin treatment <italic>in vitro</italic> and compared them with wild-type (WT) animals (<xref rid="f0010" ref-type="fig">Fig.Â 2</xref>F). We confirmed the results obtained in human Tconv cells since chronic leptin deficiency associated with high levels of autophagy compared with WT mice; in both animals leptin treatment significantly reduced autophagy (<xref rid="f0010" ref-type="fig">Fig.Â 2</xref>F).</p>
        <p>Since it is well known that leptin is able to maintain CD4<sup>+</sup> T cell survival <italic>in vitro</italic> and <italic>in vivo</italic> by up-regulation of the pro-survival/anti-apoptotic gene Bcl-2 <xref rid="bb0045" ref-type="bibr">[9]</xref>, we confirmed these results in our experimental conditions by assessing Bcl-2 levels in BAF/3-hLepRb<sup>+</sup> and human Tconv (<xref rid="f0015" ref-type="fig">Fig.Â 3</xref>A and B). This effect on Bcl-2 was regulated by PI3K-mTOR axis, as either Ly294002 (a PI3K-inhibitor) or rapamycin pre-treatment reduced Bcl-2 levels; these phenomena were both partly reversible upon leptin treatment (<xref rid="f0015" ref-type="fig">Fig.Â 3</xref>A and B).</p>
        <p>To get further insights into the molecular machinery controlled by leptin in the context of autophagy, we analyzed the interaction between the anti-autophagy Bcl-2 protein and Beclin-1, a key element of the autophagic cascade <xref rid="bb0140 bb0145 bb0150" ref-type="bibr">[28â30]</xref>. Of note, in our experimental conditions, we found that Bcl-2 co-immunoprecipitated with Beclin-1, thus suggesting a physical interaction between the anti-autophagy Bcl-2 and Beclin-1 (<xref rid="f0015" ref-type="fig">Fig.Â 3</xref>C left). These findings suggest that leptin inhibits autophagy by favoring the Bcl-2 up-regulation and consequent interaction and inhibition of Beclin-1.</p>
      </sec>
    </sec>
    <sec sec-type="discussion" id="s0060">
      <label>4</label>
      <title>Discussion</title>
      <p>In this report we show that leptin, through mTOR, regulates autophagy and this effect occurs both in a leptin-dependent system such as the BAF/3-hLepRb<sup>+</sup> transfectants and in human primary CD4<sup>+</sup>CD25<sup>â</sup> Tconv cells. It is well corroborated that leptin plays pleiotropic functions on the immune system by signaling that sufficient amount of energy is stored as fat in body reserves <xref rid="bb0155" ref-type="bibr">[31]</xref>. Since leptin activates mTOR <xref rid="bb0035 bb0040 bb0045" ref-type="bibr">[7â9]</xref> (which has key functions in controlling the autophagic process) we asked whether this cytokine-like hormone could affect this process. Autophagy is involved in the development and/or homeostasis of several immune cell populations <xref rid="bb0160" ref-type="bibr">[32]</xref>. Indeed the knockout of different autophagy genes in specific lymphocyte populations in mice has shown a crucial role for autophagy proteins in the development and maintenance of normal numbers of B cells, CD4<sup>+</sup> T cells, CD8<sup>+</sup> T cells, in antigen presentation and in the elimination of autoreactive T cells in the thymus <xref rid="bb0095 bb0100 bb0105 bb0110 bb0115 bb0120 bb0125" ref-type="bibr">[19â25]</xref>. Moreover, both autophagy and leptin have been suggested to play a key role in the modulation of the onset and outcome of several autoimmune diseases <xref rid="bb0165" ref-type="bibr">[33]</xref>. Recent evidence suggests that autophagy, through the modulation of antigen presentation, is involved in presentation of citrullinate peptide, a hallmark of RA <xref rid="bb0170" ref-type="bibr">[34]</xref>, and in the activation of CD8<sup>+</sup> T cells for the elimination of microorganisms during infection <xref rid="bb0175" ref-type="bibr">[35]</xref>. Interestingly, it has been shown that autophagy is implicated also in the survival of autoreactive B cells in SLE <xref rid="bb0180" ref-type="bibr">[36]</xref> and genome-wide association studies have shown association between single nucleotide polymorphism (SNP) in some autophagy related genes (ATG) with susceptibility to SLE <xref rid="bb0185" ref-type="bibr">[37]</xref>, RA <xref rid="bb0190" ref-type="bibr">[38]</xref> and Crohn's disease <xref rid="bb0195" ref-type="bibr">[39]</xref>.</p>
      <p>Recent evidence indicates that leptin also promotes autoimmune disorders by enhancing pro-inflammatory cytokine secretion and immune responses <xref rid="bb0200" ref-type="bibr">[40]</xref>. In several autoimmune diseases, such as RA high serum leptin levels have been found <xref rid="bb0205 bb0210" ref-type="bibr">[41,42]</xref>, while, on the contrary, fasting, which associates with a marked decrease in serum leptin amount and a shift toward Th2-type cytokine secretion, improves clinical disease activity in RA patients <xref rid="bb0215" ref-type="bibr">[43]</xref>. Furthermore leptin has been shown to promote Th17 responses in normal human CD4<sup>+</sup> T cells and in (NZB X NZW) F1 lupus-prone mice, by inducing RORÎ³ transcription, whereas, on the contrary, its neutralization in those autoimmune-prone mice inhibits Th17 responses <xref rid="bb0220" ref-type="bibr">[44]</xref>. Leptin has also been linked to spontaneous autoimmune disease such as type 1 diabetes (T1D) in the non-obese diabetic (NOD) mice <xref rid="bb0225" ref-type="bibr">[45]</xref> and in the induction and progression of EAE, a mouse model of MS <xref rid="bb0230 bb0235" ref-type="bibr">[46,47]</xref>. Moreover, leptin can negatively modulate the expansion of human Treg cells <xref rid="bb0030" ref-type="bibr">[6]</xref> a cellular subset, which suppress autoreactive response mediated by Tconv cells thus suggesting a central role exerted by leptin in the pathogenesis of several autoimmune diseases. Leptin influences Tconv cell functions through mTOR activation thus causing a defined cellular, biochemical and transcriptional modification that determines the outcome of their responses, both <italic>in vitro</italic> and <italic>in vivo</italic> and also confirming that this pathway might integrate cellular energy status with metabolic-related signaling in Treg/Tconv that use this information to control immune tolerance <xref rid="bb0035" ref-type="bibr">[7]</xref>.</p>
      <p>We observed a distinct capacity of leptin to inhibit the autophagic process in human Tconv cells. This phenomenon was rapid and early, sustained by the TCR engagement, which was able alone to inhibit autophagy at maximal level (<xref rid="f0010" ref-type="fig">Fig.Â 2</xref>B). The capacity of leptin to reduce autophagy was also confirmed in the Tconv cells from the leptin-deficient <italic>ob/ob</italic> mouse (<xref rid="f0010" ref-type="fig">Fig.Â 2</xref>F), since these cells showed a high level of autophagy when compared with WT counterparts (<xref rid="f0010" ref-type="fig">Fig.Â 2</xref>F). In this report we further a possible molecular mechanism accounting for the capacity of leptin to activate the anti-apoptotic gene Bcl-2 which in turn is able to physically interact and subtract Beclin-1 from the autophagic cascade (<xref rid="f0015" ref-type="fig">Fig.Â 3</xref>C). These data are in agreement with reports showing <italic>in vivo</italic> that leptin activates pro-survival pathways, including Bcl-2 <xref rid="bb0045" ref-type="bibr">[9]</xref>, which in turn has determinant activities also on the autophagic machinery <italic>via</italic> its physical interaction with Beclin-1 <xref rid="bb0140" ref-type="bibr">[28]</xref>.</p>
      <p>Finally, our report unveils a novel mechanism of control exerted by nutritional status and metabolism on Tconv cells <italic>via</italic> leptin's control on autophagy. These effects can partly explain some of the well known anti-inflammatory activities induced by either nutritional deprivation or rapamycin treatment both able to significantly reduce circulating leptin, Tconv cell proliferation and consequently systemic inflammation.</p>
    </sec>
    <sec id="s0065">
      <title>Author contribution</title>
      <p>G.M. and S.C. designed the research; S.C., V.P., C.L.R., V.D.R., C.P. and G.M. conducted the study; S.C., V.P., C.L.R., V.D.R., C.P., G.M. and G.M. analyzed data and interpreted results; S.C., V.P., C.L.R. G.M., and G.M., revised the article critically; S.C., V.P. and C.L.R. performed statistical analysis; S.C., V.P. and G.M., wrote manuscript and approved its final version.</p>
    </sec>
    <sec id="s0070">
      <title>Conflict of interest</title>
      <p>The authors declare no competing financial interests.</p>
      <p>The following are the supplementary data related to this article.<supplementary-material content-type="local-data" id="ec1005"><caption><title>Supplemental Fig.Â 1.</title><p>Leptin specifically reduces autophagy in BAF/3-hLepRb<sup>+</sup> cells.</p><p>Densitometric analysis of LC3-II/LC3-I in BAF/3-hLepRb<sup>+</sup> cells. Cells were stimulated or not with leptin (100Â ng/mL), in presence or absence of lysosomal protease inhibitors NH<sub>4</sub>Cl (20Â mmol/L) and leupeptin (100Â Î¼mol/L). LC3-II was also normalized against actin. Densitometric analysis represents the meanÂ Â±Â S.E.M. of at least three experiments one representative out of three independent experiments (<sup>ââ</sup><italic>p</italic>Â &lt;Â 0.03).</p></caption><media xlink:href="mmc1.pdf"/></supplementary-material><supplementary-material content-type="local-data" id="ec0010"><caption><title>Supplemental Fig.Â 2.</title><p>P-ERK1/2 levels in Tconv cells upon leptin stimulation in basal conditions and upon TCR-stimulation.</p><p>Densitometric analysis P-ERK1/2/ERK1/2 in human Tconv cells stimulated for 120â² with increasing human leptin concentrations (100â200Â ng/mL) plus anti-CD3/CD28 (0,2 beads/cell) (<bold>A</bold>) and in presence or not of rapamycin (60â² at 100 nmol/L) (<bold>B</bold>). Representative of at least three independent experiments. Data are shown as meanÂ Â±Â S.E.M. (<sup>â</sup><italic>p</italic>Â &lt;Â 0.05).</p></caption><media xlink:href="mmc2.pdf"/></supplementary-material></p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="bb0005">
        <label>1</label>
        <element-citation publication-type="journal" id="rf0005">
          <person-group person-group-type="author">
            <name>
              <surname>Fiedman</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Halaas</surname>
              <given-names>J.L.</given-names>
            </name>
          </person-group>
          <article-title>Leptin and the regulation of body weight in mammals</article-title>
          <source>Nature</source>
          <volume>395</volume>
          <year>1998</year>
          <fpage>763</fpage>
          <lpage>770</lpage>
          <pub-id pub-id-type="pmid">9796811</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0010">
        <label>2</label>
        <element-citation publication-type="journal" id="rf0010">
          <person-group person-group-type="author">
            <name>
              <surname>Tartaglia</surname>
              <given-names>L.A.</given-names>
            </name>
            <name>
              <surname>Demski</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Weng</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Deng</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Culpepper</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Devos</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Identification and expression cloning of the leptin receptor Ob-R</article-title>
          <source>Cell</source>
          <volume>83</volume>
          <year>1995</year>
          <fpage>1263</fpage>
          <lpage>1271</lpage>
          <pub-id pub-id-type="pmid">8548812</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0015">
        <label>3</label>
        <element-citation publication-type="journal" id="rf0015">
          <person-group person-group-type="author">
            <name>
              <surname>FrÃ¼hbeck</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Salvador</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Relation between leptin and glucose metabolism</article-title>
          <source>Diabetologia</source>
          <volume>43</volume>
          <year>2000</year>
          <fpage>3</fpage>
          <lpage>12</lpage>
          <pub-id pub-id-type="pmid">10663211</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0020">
        <label>4</label>
        <element-citation publication-type="journal" id="rf0020">
          <person-group person-group-type="author">
            <name>
              <surname>Matarese</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Leptin and immune system: how nutritional status influences the immune response</article-title>
          <source>Eur Cytokine Netw</source>
          <volume>11</volume>
          <year>2000</year>
          <fpage>7</fpage>
          <lpage>13</lpage>
          <pub-id pub-id-type="pmid">10705294</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0025">
        <label>5</label>
        <element-citation publication-type="journal" id="rf0025">
          <person-group person-group-type="author">
            <name>
              <surname>Lord</surname>
              <given-names>G.M.</given-names>
            </name>
            <name>
              <surname>Matarese</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Howard</surname>
              <given-names>J.K.</given-names>
            </name>
            <name>
              <surname>Baker</surname>
              <given-names>R.J.</given-names>
            </name>
            <name>
              <surname>Bloom</surname>
              <given-names>S.R.</given-names>
            </name>
            <name>
              <surname>Lechler</surname>
              <given-names>R.I.</given-names>
            </name>
          </person-group>
          <article-title>Leptin modulates the T-cells immune response and reverses starvation-induced immunosuppression</article-title>
          <source>Nature</source>
          <volume>394</volume>
          <year>1998</year>
          <fpage>897</fpage>
          <lpage>901</lpage>
          <pub-id pub-id-type="pmid">9732873</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0030">
        <label>6</label>
        <element-citation publication-type="journal" id="rf0030">
          <person-group person-group-type="author">
            <name>
              <surname>De Rosa</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Procaccini</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>CalÃ¬</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Pirozzi</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Fontana</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Zappacosta</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Key role of leptin in the control of regulatory T cells proliferation</article-title>
          <source>Immunity</source>
          <volume>26</volume>
          <year>2007</year>
          <fpage>241</fpage>
          <lpage>255</lpage>
          <pub-id pub-id-type="pmid">17307705</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0035">
        <label>7</label>
        <element-citation publication-type="journal" id="rf0035">
          <person-group person-group-type="author">
            <name>
              <surname>Procaccini</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>De Rosa</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Galgani</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Carbone</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Cassano</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Greco</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Leptin-induced mTOR activation defines a specific molecular and transcriptional signature controlling CD4<sup>+</sup> effector T cell responses</article-title>
          <source>J Immunol</source>
          <volume>189</volume>
          <year>2012</year>
          <fpage>2941</fpage>
          <lpage>2953</lpage>
          <pub-id pub-id-type="pmid">22904304</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0040">
        <label>8</label>
        <element-citation publication-type="journal" id="rf0040">
          <person-group person-group-type="author">
            <name>
              <surname>Procaccini</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>De Rosa</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Galgani</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Abanni</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>CalÃ¬</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Porcellini</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>An oscillatory switch in mTOR Kinase activity sets regulatory T cell responsiveness</article-title>
          <source>Immunity</source>
          <volume>33</volume>
          <year>2010</year>
          <fpage>1</fpage>
          <lpage>13</lpage>
          <pub-id pub-id-type="pmid">20643331</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0045">
        <label>9</label>
        <element-citation publication-type="journal" id="rf0045">
          <person-group person-group-type="author">
            <name>
              <surname>Galgani</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Procaccini</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>De Rosa</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Carbone</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Chieffi</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>La Cava</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Leptin modulates the survival of autoreactive CD4<sup>+</sup> T cells through the nutrient/energy-sensing mammalian target of rapamycin signaling pathway</article-title>
          <source>J Immunol</source>
          <volume>185</volume>
          <year>2010</year>
          <fpage>7474</fpage>
          <lpage>7479</lpage>
          <pub-id pub-id-type="pmid">21078910</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0050">
        <label>10</label>
        <element-citation publication-type="journal" id="rf0050">
          <person-group person-group-type="author">
            <name>
              <surname>Wood</surname>
              <given-names>S.C.</given-names>
            </name>
            <name>
              <surname>Seeley</surname>
              <given-names>R.J.</given-names>
            </name>
            <name>
              <surname>Cota</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Regulation of food intake through hypothalamic signaling networks involving mTOR</article-title>
          <source>Annu Rev Nutr</source>
          <volume>28</volume>
          <year>2008</year>
          <fpage>295</fpage>
          <lpage>331</lpage>
          <pub-id pub-id-type="pmid">18429698</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0055">
        <label>11</label>
        <element-citation publication-type="journal" id="rf0055">
          <person-group person-group-type="author">
            <name>
              <surname>Noda</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Ohsumi</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>Tor, a phosphatidylinositol kinase homologue, controls autophagy in yeast</article-title>
          <source>J Biol Chem</source>
          <volume>273</volume>
          <year>1998</year>
          <fpage>3963</fpage>
          <lpage>3966</lpage>
          <pub-id pub-id-type="pmid">9461583</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0060">
        <label>12</label>
        <element-citation publication-type="journal" id="rf0060">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Kundu</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Viollet</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Guan</surname>
              <given-names>K.L.</given-names>
            </name>
          </person-group>
          <article-title>AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1</article-title>
          <source>Nat Cell Biol</source>
          <volume>13</volume>
          <year>2011</year>
          <fpage>132</fpage>
          <lpage>141</lpage>
          <pub-id pub-id-type="pmid">21258367</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0065">
        <label>13</label>
        <element-citation publication-type="journal" id="rf0065">
          <person-group person-group-type="author">
            <name>
              <surname>Jung</surname>
              <given-names>C.H.</given-names>
            </name>
            <name>
              <surname>Ro</surname>
              <given-names>S.H.</given-names>
            </name>
            <name>
              <surname>Cao</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Otto</surname>
              <given-names>N.M.</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>D.H.</given-names>
            </name>
          </person-group>
          <article-title>mTOR regulation of autophagy</article-title>
          <source>FEBS Lett</source>
          <volume>584</volume>
          <year>2010</year>
          <fpage>1287</fpage>
          <lpage>1295</lpage>
          <pub-id pub-id-type="pmid">20083114</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0070">
        <label>14</label>
        <element-citation publication-type="journal" id="rf0070">
          <person-group person-group-type="author">
            <name>
              <surname>Sengupta</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Peterson</surname>
              <given-names>T.R.</given-names>
            </name>
            <name>
              <surname>Sabatini</surname>
              <given-names>D.M.</given-names>
            </name>
          </person-group>
          <article-title>Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress</article-title>
          <source>Mol Cell</source>
          <volume>40</volume>
          <year>2010</year>
          <fpage>310</fpage>
          <lpage>322</lpage>
          <pub-id pub-id-type="pmid">20965424</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0075">
        <label>15</label>
        <element-citation publication-type="journal" id="rf0075">
          <person-group person-group-type="author">
            <name>
              <surname>Scott</surname>
              <given-names>R.C.</given-names>
            </name>
            <name>
              <surname>Schuldiner</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Neufeld</surname>
              <given-names>T.P.</given-names>
            </name>
          </person-group>
          <article-title>Role and regulation of starvation-induced autophagy in the Drosophila fat body</article-title>
          <source>Dev Cell</source>
          <volume>7</volume>
          <year>2004</year>
          <fpage>167</fpage>
          <lpage>178</lpage>
          <pub-id pub-id-type="pmid">15296714</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0080">
        <label>16</label>
        <element-citation publication-type="journal" id="rf0080">
          <person-group person-group-type="author">
            <name>
              <surname>Eisembenberg-Lerner</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Bialik</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Simon</surname>
              <given-names>H.U.</given-names>
            </name>
            <name>
              <surname>Kimchi</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Life and death partners apoptosis, autophagy and the cross-talk between them</article-title>
          <source>Cell Death Differ</source>
          <volume>16</volume>
          <year>2009</year>
          <fpage>966</fpage>
          <lpage>975</lpage>
          <pub-id pub-id-type="pmid">19325568</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0085">
        <label>17</label>
        <element-citation publication-type="journal" id="rf0085">
          <person-group person-group-type="author">
            <name>
              <surname>Kroemer</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Levine</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>Autophagy cell death: the story of misnomer</article-title>
          <source>Nat Rev Mol Cell Biol</source>
          <volume>9</volume>
          <year>2008</year>
          <fpage>1004</fpage>
          <lpage>1010</lpage>
          <pub-id pub-id-type="pmid">18971948</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0090">
        <label>18</label>
        <element-citation publication-type="journal" id="rf0090">
          <person-group person-group-type="author">
            <name>
              <surname>Levine</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Yuan</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Autophagy in cell death an innocent convict</article-title>
          <source>J Clin Invest</source>
          <volume>115</volume>
          <year>2005</year>
          <fpage>2679</fpage>
          <lpage>2688</lpage>
          <pub-id pub-id-type="pmid">16200202</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0095">
        <label>19</label>
        <element-citation publication-type="journal" id="rf0095">
          <person-group person-group-type="author">
            <name>
              <surname>Virgin</surname>
              <given-names>H.W.</given-names>
            </name>
            <name>
              <surname>Levine</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>Autophagy genes in immunity</article-title>
          <source>Nat Immunol</source>
          <volume>10</volume>
          <year>2009</year>
          <fpage>461</fpage>
          <lpage>470</lpage>
          <pub-id pub-id-type="pmid">19381141</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0100">
        <label>20</label>
        <element-citation publication-type="journal" id="rf0100">
          <person-group person-group-type="author">
            <name>
              <surname>He</surname>
              <given-names>M.X.</given-names>
            </name>
            <name>
              <surname>McLeod</surname>
              <given-names>I.X.</given-names>
            </name>
            <name>
              <surname>Jia</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>He</surname>
              <given-names>Y.W.</given-names>
            </name>
          </person-group>
          <article-title>Macroautophagy in T lymphocyte development and function</article-title>
          <source>Front Immunol</source>
          <volume>21</volume>
          <year>2012</year>
          <fpage>3</fpage>
          <lpage>22</lpage>
        </element-citation>
      </ref>
      <ref id="bb0105">
        <label>21</label>
        <element-citation publication-type="journal" id="rf0105">
          <person-group person-group-type="author">
            <name>
              <surname>Jia</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>He</surname>
              <given-names>Y.W.</given-names>
            </name>
          </person-group>
          <article-title>Temporal regulation of intracellular organelle homeostasis in T lymphocytes by autophagy</article-title>
          <source>J Immunol</source>
          <volume>186</volume>
          <year>2011</year>
          <fpage>5313</fpage>
          <lpage>5322</lpage>
          <pub-id pub-id-type="pmid">21421856</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0110">
        <label>22</label>
        <element-citation publication-type="journal" id="rf0110">
          <person-group person-group-type="author">
            <name>
              <surname>Paul</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Schaefer</surname>
              <given-names>B.C.</given-names>
            </name>
          </person-group>
          <article-title>Selective autophagy regulates T cell activation</article-title>
          <source>Autophagy</source>
          <volume>8</volume>
          <year>2012</year>
          <fpage>1690</fpage>
          <lpage>1692</lpage>
          <pub-id pub-id-type="pmid">22874554</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0115">
        <label>23</label>
        <element-citation publication-type="journal" id="rf0115">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Capan</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Stolz</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Watkins</surname>
              <given-names>S.C.</given-names>
            </name>
          </person-group>
          <article-title>Autophagy is induced in CD4<sup>+</sup> T cells and important for the growth factor-withdrawal cell death</article-title>
          <source>J Immunol</source>
          <volume>177</volume>
          <year>2006</year>
          <fpage>5163</fpage>
          <lpage>5168</lpage>
          <pub-id pub-id-type="pmid">17015701</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0120">
        <label>24</label>
        <element-citation publication-type="journal" id="rf0120">
          <person-group person-group-type="author">
            <name>
              <surname>Nedjic</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Aichinger</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Emmerich</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Mizushima</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Klein</surname>
              <given-names>L.</given-names>
            </name>
          </person-group>
          <article-title>Autophagy in thymic epithelium shapes the T-cell repertoire and is essential for tolerance</article-title>
          <source>Nature</source>
          <volume>455</volume>
          <year>2008</year>
          <fpage>396</fpage>
          <lpage>400</lpage>
          <pub-id pub-id-type="pmid">18701890</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0125">
        <label>25</label>
        <element-citation publication-type="journal" id="rf0125">
          <person-group person-group-type="author">
            <name>
              <surname>Schmid</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Pypaert</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>MÃ¼nz</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes</article-title>
          <source>Immunity</source>
          <volume>26</volume>
          <year>2007</year>
          <fpage>79</fpage>
          <lpage>92</lpage>
          <pub-id pub-id-type="pmid">17182262</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0130">
        <label>26</label>
        <element-citation publication-type="journal" id="rf0130">
          <person-group person-group-type="author">
            <name>
              <surname>Conde</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Scotece</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>GÃ³mez</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>GÃ³mez-Reino</surname>
              <given-names>J.J.</given-names>
            </name>
            <name>
              <surname>Lago</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Gualillo</surname>
              <given-names>O.</given-names>
            </name>
          </person-group>
          <article-title>At the crossroad between immunity and metabolism: focus on leptin</article-title>
          <source>Expert Rev Clin Immunol</source>
          <volume>6</volume>
          <year>2010</year>
          <fpage>801</fpage>
          <lpage>808</lpage>
          <pub-id pub-id-type="pmid">20828288</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0135">
        <label>27</label>
        <element-citation publication-type="journal" id="rf0135">
          <person-group person-group-type="author">
            <name>
              <surname>Matarese</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Leiter</surname>
              <given-names>E.H.</given-names>
            </name>
            <name>
              <surname>La Cava</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Leptin in autoimmunity: many questions, some answers</article-title>
          <source>Tissue Antigens</source>
          <volume>70</volume>
          <year>2007</year>
          <fpage>87</fpage>
          <lpage>95</lpage>
          <pub-id pub-id-type="pmid">17610413</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0140">
        <label>28</label>
        <element-citation publication-type="journal" id="rf0140">
          <person-group person-group-type="author">
            <name>
              <surname>Pattingre</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Tassa</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Qu</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Garuti</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Liang</surname>
              <given-names>X.H.</given-names>
            </name>
            <name>
              <surname>Mizushima</surname>
              <given-names>N.</given-names>
            </name>
          </person-group>
          <article-title>Bcl-2 antiapoptotic proteins inhibit Beclin 1 dependent autophagy</article-title>
          <source>Cell</source>
          <volume>122</volume>
          <year>2005</year>
          <fpage>927</fpage>
          <lpage>939</lpage>
          <pub-id pub-id-type="pmid">16179260</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0145">
        <label>29</label>
        <element-citation publication-type="journal" id="rf0145">
          <person-group person-group-type="author">
            <name>
              <surname>He</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Bassik</surname>
              <given-names>M.C.</given-names>
            </name>
            <name>
              <surname>Moresi</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Wei</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Zou</surname>
              <given-names>Z.</given-names>
            </name>
          </person-group>
          <article-title>Exercise-induced BCL2-regulated autophagy is required for muscle glucose homeostasis</article-title>
          <source>Nature</source>
          <volume>481</volume>
          <year>2012</year>
          <fpage>511</fpage>
          <lpage>515</lpage>
          <pub-id pub-id-type="pmid">22258505</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0150">
        <label>30</label>
        <element-citation publication-type="journal" id="rf0150">
          <person-group person-group-type="author">
            <name>
              <surname>Maejima</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Kyoi</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Zhai</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Ivessa</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Mst1 inhibits autophagy by promoting the interaction between Beclin1 and Bcl-2</article-title>
          <source>Nat Med</source>
          <volume>19</volume>
          <year>2013</year>
          <fpage>1478</fpage>
          <lpage>1488</lpage>
          <pub-id pub-id-type="pmid">24141421</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0155">
        <label>31</label>
        <element-citation publication-type="journal" id="rf0155">
          <person-group person-group-type="author">
            <name>
              <surname>La Cava</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Matarese</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>The weight of leptin in immunity</article-title>
          <source>Nat Rev Immunol</source>
          <volume>4</volume>
          <year>2004</year>
          <fpage>371</fpage>
          <lpage>379</lpage>
          <pub-id pub-id-type="pmid">15122202</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0160">
        <label>32</label>
        <element-citation publication-type="journal" id="rf0160">
          <person-group person-group-type="author">
            <name>
              <surname>Puleston</surname>
              <given-names>D.J.</given-names>
            </name>
            <name>
              <surname>Simon</surname>
              <given-names>A.K.</given-names>
            </name>
          </person-group>
          <article-title>Autophagy in the immune system</article-title>
          <source>Immunology</source>
          <volume>141</volume>
          <year>2013</year>
          <fpage>1</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">23991647</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0165">
        <label>33</label>
        <element-citation publication-type="journal" id="rf0165">
          <person-group person-group-type="author">
            <name>
              <surname>Bhattacharya</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Eissa</surname>
              <given-names>N.T.</given-names>
            </name>
          </person-group>
          <article-title>Autophagy and autoimmunity crosstalks</article-title>
          <source>Front Immunol</source>
          <volume>4</volume>
          <year>2013</year>
          <fpage>1</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">23355837</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0170">
        <label>34</label>
        <element-citation publication-type="journal" id="rf0170">
          <person-group person-group-type="author">
            <name>
              <surname>Ireland</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Unanue</surname>
              <given-names>E.R.</given-names>
            </name>
          </person-group>
          <article-title>Autophagy in antigen-presenting cells results in presentation of citrullinated peptides to CD4<sup>+</sup> T cells</article-title>
          <source>J Exp Med</source>
          <volume>208</volume>
          <year>2011</year>
          <fpage>2625</fpage>
          <lpage>2632</lpage>
          <pub-id pub-id-type="pmid">22162830</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0175">
        <label>35</label>
        <element-citation publication-type="journal" id="rf0175">
          <person-group person-group-type="author">
            <name>
              <surname>Deretic</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Saitoh</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Akira</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Autophagy in infection, inflammation and immunity</article-title>
          <source>Nat Rev Immunol</source>
          <volume>13</volume>
          <year>2013</year>
          <fpage>722</fpage>
          <lpage>737</lpage>
          <pub-id pub-id-type="pmid">24064518</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0180">
        <label>36</label>
        <element-citation publication-type="journal" id="rf0180">
          <person-group person-group-type="author">
            <name>
              <surname>Clarke</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Ellinghaus</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Cortini</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Stranks</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Simon</surname>
              <given-names>A.K.</given-names>
            </name>
            <name>
              <surname>Botto</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Autophagy is activated in systemic lupus erythematosus and required for plasmablast development</article-title>
          <source>Ann Rheum Dis</source>
          <year>2014</year>
          <fpage>1</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">24092418</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0185">
        <label>37</label>
        <element-citation publication-type="journal" id="rf0185">
          <person-group person-group-type="author">
            <name>
              <surname>Harley</surname>
              <given-names>J.B.</given-names>
            </name>
            <name>
              <surname>Alarcon-Riquelme</surname>
              <given-names>M.E.</given-names>
            </name>
            <name>
              <surname>Criswell</surname>
              <given-names>L.A.</given-names>
            </name>
            <name>
              <surname>Jacob</surname>
              <given-names>C.O.</given-names>
            </name>
            <name>
              <surname>Kimberly</surname>
              <given-names>R.P.</given-names>
            </name>
            <name>
              <surname>Moser</surname>
              <given-names>K.L.</given-names>
            </name>
          </person-group>
          <article-title>Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci</article-title>
          <source>Nat Genet</source>
          <volume>40</volume>
          <year>2008</year>
          <fpage>204</fpage>
          <lpage>210</lpage>
          <pub-id pub-id-type="pmid">18204446</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0190">
        <label>38</label>
        <element-citation publication-type="journal" id="rf0190">
          <person-group person-group-type="author">
            <name>
              <surname>Raychaudhuri</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Thomson</surname>
              <given-names>B.P.</given-names>
            </name>
            <name>
              <surname>Remmers</surname>
              <given-names>E.F.</given-names>
            </name>
            <name>
              <surname>Eyre</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Hinks</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Guiducci</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk</article-title>
          <source>Nat Genet</source>
          <volume>41</volume>
          <year>2009</year>
          <fpage>1313</fpage>
          <lpage>1318</lpage>
          <pub-id pub-id-type="pmid">19898481</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0195">
        <label>39</label>
        <element-citation publication-type="journal" id="rf0195">
          <person-group person-group-type="author">
            <name>
              <surname>Parkes</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Barrett</surname>
              <given-names>J.C.</given-names>
            </name>
            <name>
              <surname>Prescott</surname>
              <given-names>N.J.</given-names>
            </name>
            <name>
              <surname>Tremelling</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>C.A.</given-names>
            </name>
            <name>
              <surname>Fisher</surname>
              <given-names>S.A.</given-names>
            </name>
          </person-group>
          <article-title>Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility</article-title>
          <source>Nat Genet</source>
          <volume>39</volume>
          <year>2007</year>
          <fpage>830</fpage>
          <lpage>832</lpage>
          <pub-id pub-id-type="pmid">17554261</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0200">
        <label>40</label>
        <element-citation publication-type="journal" id="rf0240">
          <person-group person-group-type="author">
            <name>
              <surname>Procaccini</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Pucino</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>De Rosa</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Marone</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Matarese</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Neuro-endocrine networks controlling immune system in health and disease</article-title>
          <source>Front Immunol</source>
          <volume>5</volume>
          <year>2014</year>
          <fpage>1</fpage>
          <lpage>10</lpage>
          <pub-id pub-id-type="pmid">24474949</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0205">
        <label>41</label>
        <element-citation publication-type="journal" id="rf0205">
          <person-group person-group-type="author">
            <name>
              <surname>GÃ³mez</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Conde</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Scotece</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>GÃ³mez-Reino</surname>
              <given-names>J.J.</given-names>
            </name>
            <name>
              <surname>Lago</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Gualillo</surname>
              <given-names>O.</given-names>
            </name>
          </person-group>
          <article-title>What's new in our understanding of the role of adipokines in rheumatic diseases?</article-title>
          <source>Nat Rev Rheumatol</source>
          <volume>7</volume>
          <year>2011</year>
          <fpage>528</fpage>
          <lpage>536</lpage>
          <pub-id pub-id-type="pmid">21808287</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0210">
        <label>42</label>
        <element-citation publication-type="journal" id="rf0210">
          <person-group person-group-type="author">
            <name>
              <surname>Scotece</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Conde</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Lopez</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Lago</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Pino</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Gomez-Reino</surname>
              <given-names>J.J.</given-names>
            </name>
          </person-group>
          <article-title>Leptin in joint and bone diseases: new insights</article-title>
          <source>Curr Med Chem</source>
          <volume>20</volume>
          <year>2013</year>
          <fpage>3416</fpage>
          <lpage>3425</lpage>
          <pub-id pub-id-type="pmid">23746275</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0215">
        <label>43</label>
        <element-citation publication-type="journal" id="rf0215">
          <person-group person-group-type="author">
            <name>
              <surname>Fraser</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Thoen</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Reseland</surname>
              <given-names>J.E.</given-names>
            </name>
            <name>
              <surname>FÃ¸rre</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Kjeldsen-Kragh</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Decreased CD4<sup>+</sup> lymphocyte activation and increased interleukin-4 production in peripheral blood of rheumatoid arthritis patients after acute starvation</article-title>
          <source>Clin Rheumatol</source>
          <volume>18</volume>
          <year>1999</year>
          <fpage>394</fpage>
          <lpage>401</lpage>
          <pub-id pub-id-type="pmid">10524554</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0220">
        <label>44</label>
        <element-citation publication-type="journal" id="rf0245">
          <person-group person-group-type="author">
            <name>
              <surname>Yu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Shi</surname>
              <given-names>F.D.</given-names>
            </name>
            <name>
              <surname>Zou</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Matarese</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>La Cava</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Cutting edge: leptin-induced RORÎ³t expression in CD4Â + T cells promotes Th17 response in systemic lupus erythematosus</article-title>
          <source>J Immunol</source>
          <volume>190</volume>
          <year>2013</year>
          <fpage>3054</fpage>
          <lpage>3058</lpage>
          <pub-id pub-id-type="pmid">23447682</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0225">
        <label>45</label>
        <element-citation publication-type="journal" id="rf0225">
          <person-group person-group-type="author">
            <name>
              <surname>Matarese</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Sanna</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Lechler</surname>
              <given-names>R.I.</given-names>
            </name>
            <name>
              <surname>Sarvetnick</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Fontana</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Zappacosta</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Leptin accelerates autoimmune diabetes in female NOD mice</article-title>
          <source>Diabetes</source>
          <volume>51</volume>
          <year>2002</year>
          <fpage>1356</fpage>
          <lpage>1361</lpage>
          <pub-id pub-id-type="pmid">11978630</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0230">
        <label>46</label>
        <element-citation publication-type="journal" id="rf0230">
          <person-group person-group-type="author">
            <name>
              <surname>Matarese</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Di Giacomo</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Sanna</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Lord</surname>
              <given-names>G.M.</given-names>
            </name>
            <name>
              <surname>Howard</surname>
              <given-names>J.K.</given-names>
            </name>
            <name>
              <surname>Di Tuoro</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Requirement for leptin in the induction and progression of autoimmune encephalomyelitis</article-title>
          <source>J Immunol</source>
          <volume>166</volume>
          <year>2001</year>
          <fpage>5909</fpage>
          <lpage>5916</lpage>
          <pub-id pub-id-type="pmid">11342605</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0235">
        <label>47</label>
        <element-citation publication-type="journal" id="rf0235">
          <person-group person-group-type="author">
            <name>
              <surname>Sanna</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Di Giacomo</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>La Cava</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Lechler</surname>
              <given-names>R.I.</given-names>
            </name>
            <name>
              <surname>Fontana</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Zappacosta</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Leptin surge precedes onset of autoimmune encephalomyelitis and correlates with development of pathogenic T cell responses</article-title>
          <source>J Clin Invest</source>
          <volume>111</volume>
          <year>2003</year>
          <fpage>241</fpage>
          <lpage>250</lpage>
          <pub-id pub-id-type="pmid">12531880</pub-id>
        </element-citation>
      </ref>
    </ref-list>
    <sec id="s0125" sec-type="supplementary-material">
      <label>Appendix A</label>
      <title>Supplementary data</title>
      <p>
        <supplementary-material content-type="local-data" id="ec0005">
          <caption>
            <p>Supplementary material</p>
          </caption>
          <media xlink:href="mmc1.pdf"/>
        </supplementary-material>
      </p>
    </sec>
    <ack id="ac0005">
      <title>Acknowledgments</title>
      <p>The work is supported by grants from <funding-source id="gts0005">FISM</funding-source> 2012/R/11, the <funding-source id="gts0010">EU Ideas Programme ERC-StG âmenTORingTregsâ</funding-source> n. 310496, <funding-source id="gts0015">CNR-Medicina Personalizzata</funding-source> Grant, the <funding-source id="gts0020">Ministero della Salute</funding-source> Grant n. GR-2010-2315414, the <funding-source id="gts0025">FIRB</funding-source> Grant n. RBFR12I3UB_004 and <funding-source id="gts0030">Regione Campania CISI-Lab</funding-source>, <funding-source id="gts0035">CREME</funding-source> and <funding-source id="gts0040">TIMING</funding-source> projects. This work is dedicated to the memory of Eugenia Papa and Serafino Zappacosta.</p>
    </ack>
  </back>
  <floats-group>
    <fig id="f0005">
      <label>Fig.Â 1</label>
      <caption>
        <p>Leptin modulates autophagy <italic>via</italic> mTOR in BAF/3-hLepRb<sup>+</sup> cells.</p>
        <p><sup>3</sup>H-thymidine incorporation in BAF/3-hLepRb<sup>+</sup> cells stimulated with human leptin (0.01â10Â ng/mL) in a dose response assay (<bold>A</bold>). Densitometric analysis of P-STAT3/STAT3 (<bold>B</bold>) and P-S6/S6 (<bold>C</bold>). Leptin (left panel) plus rapamycin (right panel) were used at 100Â ng/mL and 100Â nmol/L respectively at times shown in figures. BAF/3-hLepRb<sup>+</sup> cells cultured in the presence or absence of leptin, were stained with monodansyl-cadaverine (MDC) and analyzed by flow cytometry (<bold>D</bold>). Autophagy levels were measured also by western blotting analysis and calculated as the ratio LC3-II/LC3-I. LC3-II was also normalized against actin. BAF/3-hLepRb<sup>+</sup> cells were stimulated with leptin (left panel) plus rapamycin (right panel) at the same times and concentrations above described (<bold>E</bold>). The values shown represent the meanÂ Â±Â S.E.M. of at least three experiments one representative out of three independent experiments. <sup>â</sup><italic>p</italic>Â &lt;Â 0.05, <sup>ââ</sup><italic>p</italic>Â &lt;Â 0.03.</p>
      </caption>
      <graphic xlink:href="gr1"/>
    </fig>
    <fig id="f0010">
      <label>Fig.Â 2</label>
      <caption>
        <p>Leptin modulates autophagy <italic>via</italic> mTOR in CD4<sup>+</sup> CD25<sup>â</sup> Tconv cells.</p>
        <p><sup>3</sup>H-thymidine incorporation in human Tconv cells stimulated or not with leptin, anti-leptin neutralizing mAb or anti-CD3/CD28 beads (0.2 beads/cell), pretreated or not with rapamycin (60â²) (see Methods for details) (<bold>A</bold>). Densitometric analysis of LC3-II/LC3-I (<bold>B</bold>), P-S6/S6 (<bold>C</bold>) in human Tconv cells stimulated for 120â² with increasing human leptin concentrations (100â200Â ng/mL) plus anti-CD3/CD28 (0.2 beads/cell) and in presence or not of rapamycin (60â² at 100Â nmol/L) (<bold>D</bold>, <bold>E</bold>). Densitometric analysis of LC3-II/LC3-I ratio in extract from Tconv cells of <italic>ob/ob</italic> and WT mice stimulated or not with recombinant mouse leptin (200Â ng/mL) for 120â² (<bold>F</bold>). Cells were incubated with lysosomal protease inhibitors NH<sub>4</sub>Cl (20Â mmol/L) and leupeptin (100Â Î¼mol/L) in all experimental conditions (see Methods for details). Representative of at least three independent experiments. Data are shown as meanÂ Â±Â S.E.M. <sup>â</sup><italic>p</italic>Â &lt;Â 0.05, <sup>ââ</sup><italic>p</italic>Â &lt;Â 0.03, nsÂ =Â not significant.</p>
      </caption>
      <graphic xlink:href="gr2"/>
    </fig>
    <fig id="f0015">
      <label>Fig.Â 3</label>
      <caption>
        <p>Leptin controls autophagy <italic>via</italic> a physical interaction of Bcl-2 with Beclin-1.</p>
        <p>Densitometric analysis of Bcl-2/Actin in human CD4<sup>+</sup>CD25<sup>â</sup> Tconv cells (<bold>B</bold>) and in BAF/3-hLepRb<sup>+</sup> cells (<bold>C</bold>) after leptin stimulation (120â² at 200 and 100Â ng/mL respectively) in presence and absence of rapamycin (100Â nmol/L) (<bold>B</bold>) or Ly294002 (2.5Â Î¼mol/L) (<bold>C</bold>). Densitometric analyses represent the meanÂ Â±Â S.E.M. of at least three experiments one representative out of three independent experiments. <sup>â</sup><italic>p</italic>Â &lt;Â 0.05, <sup>ââ</sup><italic>p</italic>Â &lt;Â 0.03, nsÂ =Â not significant. Co-immunoprecipitation of Beclin-1 with Bcl-2 in BAF/3-hLepRb<sup>+</sup> cells in presence and absence of leptin (200Â ng/mL) (<bold>D</bold>), one representative experiment out of two replicates (IP, immunoprecipitate; WB, western blot; WCL, whole cell lysates).</p>
      </caption>
      <graphic xlink:href="gr3"/>
    </fig>
  </floats-group>
</article>

</metadata></record></GetRecord></OAI-PMH>